Please login to the form below

Diversity in Clinical Trials: A more inclusive approach in patient recruitment

We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient recruitment.

Between 2008 and 2018, fewer than two in three (63%) of the 230 clinical trials that led to cancer drug approvals by the Food and Drug Administration (FDA) in the US, recorded participants’ ethnicity. This lack of diversity is a major issue: studies show that different groups can respond to treatments in various ways, resulting in some medicines being prescribed differently.

This session will highlight some of the factors underpinning the lack of patient diversity in clinical trials, investigate the implications this has for patients, and discuss what we can do in practice to improve diversity in clinical trials.

Speakers
Kate Shaw - Founder/CEO - Innovative Trials
Sandra Amro - Global Clinical Trial Diversity Team Lead- Pfizer
Jane Thurston - Senior Patient Recruitment Lead - Parexel


13th June 2022

Share

Tags

Company Details

Innovative Trials

+44 (0) 1707 378 581

Contact Website

Address:
Innovative Trials Ltd, Innovative House
Avenue One
Letchworth Garden City
Hertfordshire
SG6 2WW
United Kingdom

Latest content on this profile

Innovative Trials opens first US office
We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press release here: https://bit.ly/39QVvpD Innovative Trials website: https://bit.ly/3OS4ru1 Follow our social media. LinkedIn: https://bit.ly/3zfIhLs Instagram: https://bit.ly/3zeP7AY Twitter: https://bit.ly/3zLqL3z Facebook: https://bit.ly/3PIjXZS
Innovative Trials
Accelerating patient recruitment post-COVID-19
COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.
Innovative Trials
Innovative Trials opens first US office
The leading global patient recruitment organisation has opened its first international office in the Raleigh, North Carolina
Innovative Trials
Windrush Day
Innnovative Trials' Equality & Diversity committee raises awareness around Windrush Day and the Windrush generation
Innovative Trials
Celebrating World Blood Donor Day
Each 14th June World Blood Donor day is celebrated around the world to spread awareness around the importance of giving blood.
Innovative Trials
Accelerating patient recruitment in clinical trials post COVID-19
Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to market. But recruitment is also one of the biggest challenges for trials. More than four in five studies fail to meet their recruitment deadlines, which can result in costly delays for sponsors and puts sites under increasing pressure. This issue has been exacerbated by the COVID-19 pandemic; with many trials initially put on hold and now restarting, sponsors want to make up for lost time by accelerating patient recruitment and retention. However, clinical trial staff are struggling to clear this enrollment backlog.This webinar will explore some of the key challenges to patient recruitment particularly since COVID-19, and highlight how a 'boots on the ground' approach via Clinical Enrollment Managers (CEMs) can help supercharge patient recruitment and retention strategy by:Understanding the local environment and culture in each country where sites are basedWorking with sites and developing strategies to help them overcome recruitment barriersSustained community engagement within key patient populations, including those who are traditionally underrepresented in trials
Innovative Trials